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Abstract 
 
Smoking remains the single most preventable cause of death worldwide and primary 
cause of several types of cancer, cardiovascular disease, and respiratory illness (USDHHS, 
2014). Although the prevalence of smoking among the general population continues to decline, 
the prevalence of smoking among the veteran population remains high. In addition, the 
prevalence of smoking among veterans with substance and alcohol use disorders is 2 to 3 times 
higher than in the general population. Over the years, the VA has implemented empirically-based 
treatments for smoking cessation to address the cigarette smoking epidemic. These services, 
however, are greatly underutilized. Motivational interviewing (MI) has traditionally been used to 
treat alcohol dependence; however, its efficacy for smoking cessation has been mixed. There is 
some evidence, however, suggesting that MI could be used to motivate smokers to seek 
treatment. The purpose of this study was to use a brief MI intervention to motivate veteran 
smokers undergoing treatment for substance use to seek smoking cessation services at the VA. 
We recruited 60 veterans undergoing substance and alcohol use treatment at the Substance Use 
Disorders/Intensive Outpatient Program (SUDs/IOP) at the James A. Haley VA. Participants 
were randomized to one of two groups: MI vs. active control. We hypothesized that veterans in 
the MI condition would be more likely to seek services for smoking cessation compared to those 
in the control condition. Our findings supported our hypothesis: 40% of participants in the MI 
condition sought treatment to quit smoking after the intervention compared to 23% of 
participants in the control condition (p = .03, controlling for baseline differences in cessation 
 
 
vi 
 
motivation).  In addition, we found that the MI intervention was most beneficial for individuals 
with lower baseline motivation to quit smoking. Although we did not find significant mediators 
of the effect of the intervention on our primary outcome, this study showed that a brief MI 
intervention can promote seeking of smoking cessation resources.
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Introduction 
 
Smoking remains the single most preventable cause of death worldwide, causing 
approximately 480,000 deaths per year in the U.S. alone, and costing approximately $289 billion 
in annual health-related economic losses (USDHHS, 2014). In addition, cigarette smoking is the 
cause of several types of cancer, cardiovascular disease, and respiratory illness (USDHHS, 
2014). As of 2015, the prevalence of smoking in the U.S. was 15.1% for all adults, with males 
(16.7%) smoking more than women (13.6%) (Jamal, King, Neff, Whitmill, Babb et al., 2016). 
Although the prevalence of smoking among the general population continues to decline, the 
prevalence of smoking among the veteran population remains high.  
Tobacco Use in Veteran Population  
Cigarette smoking has been historically prevalent among the military. A culture 
supporting cigarette smoking in the military dates back to as early as the Civil War, when 
inexpensive tobacco was provided to troops (Klevens, Giovino, Peddicord, Nelson, Mowery, & 
Grummer-Strawn, 1995). Later, cigarettes were sent in care packages to soldiers during WWI, 
WWII, and the Korean War (Joseph, 1994). In addition, the “smoking break” was used as a 
reward or punishment by drill instructors until the late 1980s (Cronan & Conway, 1989; 
Conway, 1998), and until recently, cigarettes were widely available inside bases at a discounted 
price. A pro-cigarette smoking culture in the military may partially explain why never smokers 
begin smoking during service (Hamlett-Berry, Davison, Kivlahan, Matthews, Hendrickson, & 
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Almenoff, 2009). In fact, being in the military is a risk factor for smoking onset (Klevens et al., 
1995). 
The prevalence of smoking among the veteran population has been reported to be as high 
as 40% (e.g., Brown, 2009; Institute of Medicine, 2009; McKinney, McIntire, Carmody, & 
Joseph, 1997; Veterans Health Administration, 2011). Veterans receiving care at Veteran Health 
Administration (VA) hospitals are more likely to smoke compared to veterans who are not part 
of the system. This difference may be explained by the high prevalence of psychiatric illness and 
substance use, and lower socioeconomic status among veterans receiving services at VA 
hospitals (e.g., McKinney et al., 1997; Veterans Health Administration, 2011). Furthermore, 
compared to non-smoking veterans, veteran smokers are more likely to be non-Hispanic, black, 
unemployed, uninsured, and have a combat history (Veterans Health Administration, 2011). 
Clearly, veteran smokers are a special population susceptible to nicotine addiction and difficulty 
quitting smoking. Thus, smoking cessation efforts targeted toward this population are warranted.  
Mental Illness, Substance Use, and Cigarette Smoking in the Veteran Population 
Individuals with mental illness are two to three times more likely to smoke (Ziedonis, 
Williams, Steinberg, Smelson, Krejci, Sussner, & Founds, 2004; Grant, Hasin, Chou, Stinson, & 
Dawson, 2004), with those in mental health treatment reporting the highest nicotine dependence 
(American Psychiatric Association, 2006). In fact, almost half of the cigarettes in the U.S. are 
consumed by individuals with mental illness (Lasser, Boyd, Woolhandler, Himmelstein, 
McCormick, & Bor, 2000). There are possible biological, psychological, social, and 
environmental factors that may lead individuals with mental illness and substance use to smoke 
heavily (Ziedonis et al., 2004). Some researchers hypothesize that there is a common 
psychological (negative affect) or genetic predisposition underlying mental illness and tobacco 
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dependence (McCaffery, Niaura, Swan, & Carmelli, 2003; Dierker, Avenevoli, Merikangas, 
Flaherty, & Stolar, 2001; Ziedonis et al., 2004). Other researchers suggest that individuals with 
mental illness smoke to reduce symptoms of depression, anxiety, boredom, or to improve 
memory and attention (Morton & Pradhan, 2001, Ziedonis et al., 2004), thus supporting the self-
medication hypothesis (Cargill, Emmons, Kahler, & Brown, 2001). Social factors, such as low 
education and unemployment, which are common among the mentally ill, have been shown to be 
risk factors for smoking (Lawn, Pols, & Barber, 2002; Ziedonis et al., 2004). 
The VA is the largest provider of mental health treatment in the U.S. (Greenberg & 
Rosenheck, 2004). Twenty-five to forty percent of veterans are treated for mental illness by the 
VA, and considerably more have untreated mental health problems (Ziedonis et al., 2004).  
Veterans with mental illness are two to three times more likely to be heavy smokers compared to 
the general population (Duffy, Kilbourne, Austin, Dalack, Woltmann, Waxmonsky, & Noonan 
2012); those with substance use disorders having the highest prevalence of smoking, even 
compared to veterans with schizophrenia, depression, and bipolar disorder (Veterans Health 
Administration, 2006; Institute of Medicine, 2009; Duffy et al., 2012). The high rate of smoking 
among veterans with mental illness could be explained by the stress experienced during service 
and the smoking-supporting culture discussed above. Veterans with psychiatric illness and 
substance use disorders have a higher likelihood of dying from tobacco related illnesses, such as 
cardiovascular and respiratory illnesses, cancer, and stroke, compared to the general population 
(e.g., Brown, Barraclough, & Inskip, 2000; Hurt, Offord, Croghan, Gomez-Dahl, Kottke et al., 
1996). Research indicates that, despite the high prevalence of smoking and difficulty quitting 
(Institute of Medicine, 2009), smokers with mental illness appear interested in quitting and 
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engage in quit attempts (e.g., Duffy, Essenmacher, Karvonen-Gutierrez, & Ewing, 2010; Lasser 
et al., 2000). 
Smoking Cessation among Veterans 
 Given the economic and health burden caused by tobacco smoking, since the late 1980s, 
the Department of Defense (DoD) and VA have put in place policies and services to restrict 
smoking and help veterans quit. Some of these policies include the restriction of use of tobacco 
products during basic training and restriction of some indoor smoking (McKinney et al., 1997). 
The VA effort to reduce tobacco smoking started with the implementation of a smoke-free policy 
inside VA hospitals and an order to stop selling tobacco products in stores inside the VA 
(McKinney et al., 1997). In addition, each VA hospital designates a coordinator to enforce 
smoke-free policies and distribute information about smoking. The majority of VA hospitals 
offer empirically-supported smoking cessation treatment (individual and group), telephone 
counseling, and nicotine replacement therapy at no charge to patients (Hamlett-Berry et al., 
2009; McKinney et al., 1997). Despite these efforts, smoking cessation services remain 
underutilized (Hamlett-Berry et al., 2009; Volpp, Levy, Asch, Berlin, Murphy et al., 2006). 
Some research suggests that even though 96% of VA hospitals offer smoking cessation services, 
the use of them is as low as 20% by veteran smokers (Hamlett-Berry et al., 2009). 
Some evidence indicates that approximately 70% of veterans report interest in quitting 
smoking (Miller,1999). Veterans with medical conditions – including tobacco related illnesses – 
are more motivated to quit compared to veterans without these conditions (Duffy, Biotti, 
Karvonen‐Gutierrez, & Essenmacher, 2011).  Although counter-intuitive, some research found 
that veterans with mental illness, especially those undergoing substance use treatment, were 
more motivated to quit than veterans without mental disorders (Duffy et al., 2011). 
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Unfortunately, motivation to quit smoking does not necessarily translate to behavior, as 
suggested by the low usage of smoking cessation services among this population (Duffy et al., 
2011). 
There are several possible explanations for the lack of translation between motivation and 
treatment-seeking behavior. Formal treatment programs may be inconvenient in outpatient 
settings due to scheduling conflicts, lack of transportation, and other barriers (Bastian et al., 
2010). Also, research suggest that most smokers want to quit on their own (e.g., Emmons & 
Goldstein, 1992; Duffy et al., 2011), possibly explaining why smokers do not get smoking 
cessation treatment, such as individual or group therapy. The inconsistency between motivation 
to quit smoking and the low use of smoking cessation treatment may indicate a need to better 
inform smokers, especially veterans, of all the resources available to them to quit smoking, from 
one-to-one treatment sessions to self-help material, provided at and outside of the VA. 
There may be other important barriers at work besides the ones presented previously that 
prevent veterans from seeking formal smoking cessation treatment, especially in the context of 
mental illness and substance use treatment. Patients and staff members often believe that 
smoking cessation can complicate substance use treatment, worsen psychiatric symptoms, and 
lead to relapse (Duffy et al., 2012). In addition, some believe that individuals with mental illness 
are not motivated to quit smoking (Acton, Prochaska, Kaplan, Small, & Hall, 2001; Ziedonis & 
Williams, 2003). There is evidence, however, that indicates that individuals with mental illness 
are very interested in quitting (e.g., Duffy et al., 2010; Lasser et al., 2000). Other research has 
shown that concurrent treatment for nicotine and drug addiction yields positive results (Fiore 
Jaen, Baker, Bailey, Bennett, Benowitz, & Dorfman, 2008; Shealy & Winn, 2014). In fact, data 
from one Florida VA hospital that has incorporated mandatory nicotine education in their 
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substance use recovery program showed that participation in nicotine recovery groups was 
related to increased motivation to quit smoking and decreased medical problems (Shealy, 
DeBaldo, Kropp, Gary, Egan-Blackwood, & Francis, 2001; Shealy & Winn, 2014). In addition, 
in that study, participation in nicotine recovery groups did not interfere with substance use 
recovery among individuals with substance use disorders, regardless of comorbid psychiatric 
diagnosis. Overall, research suggests that veteran smokers with mental illness seem to be 
motivated to quit smoking. This seems contradictory, as the use of smoking cessation services is 
low. This possibly indicates that veteran smokers with mental illness may want to quit smoking, 
but are not motivated to attend treatment. Interventions, such as Motivational Interviewing, could 
increase veteran smokers’ motivation to seek smoking cessation treatment. 
Motivational Interviewing for Smoking Cessation 
Motivational Interviewing (MI) was originally developed by Miller and Rollnick in 1991 
to treat alcohol abuse. Since then, MI has been successfully applied to a multitude of problematic 
behaviors such as diet, exercise, drug abuse, weight loss, treatment compliance, and diabetes. 
(Burke, Arkowitz, & Menchola, 2003, Knight, McGowan, Dickens, & Bundy, 2006; Rubak, 
Sandbæk, Lauritzen, & Christensen, 2005). MI was developed under the premise that motivation 
is fluid across time and contexts; therefore, it can change. (Miller, 1994). MI takes a client-
centered and goal directed approach to foster behavior change (Miller & Rollnick, 2002).  
The purpose of MI is to help clients explore and resolve discrepancies related to their 
behavior. The therapist guides the client or patient in such a way that the client becomes more 
likely to take steps toward changing a specific behavior. MI aims to explore and confront 
ambivalence through four main principles: expressing empathy, developing discrepancy, rolling 
with resistance, and supporting self-efficacy (Miller & Rollnick, 2002; Rollnick, Miller, & 
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Butler, 2008). In addition, MI focuses on identifying the problem, increasing motivation to 
change, accepting ambivalence, collaborating with the client, and letting the client set the pace 
for change (Miller & Rollnick, 2002).  There are an additional 8 strategies suggested by the 
developers of MI that help increase the likelihood of behavior change. These are providing 
advice, eliminating obstacles, offering alternative options, practicing empathy, providing 
feedback, affirming what clients say, clarifying goals, and offering help (Rollnick et al., 2008). 
Research supports the efficacy of MI in treating a myriad of problematic behaviors (e.g., 
Foley, Duran, Morris, Lucero, Jiang, Baxter et al., 2005; Burke et al., 2003, Madson, Campbell, 
Barrett, Brondino, & Melchert, 2009; Hettema, Steele& Miller, 2005). However, the efficacy of 
MI for smoking cessation is not well established, mainly because of the smaller number of 
studies and the different methodologies used (Hettema et al., 2010; Lai et al., 2010; Piñeiro, 
Míguez Varela, & Becoña Iglesias, 2010). A recent meta-analysis, however, showed a moderate 
effect of MI for smoking cessation (Lai, Cahill, Qin, & Tang, 2010). The same meta-analysis 
showed that sessions longer than 20 minutes were more effective than shorter sessions, and that 
single sessions were just as effective as multiple sessions. In general, the majority of studies 
showing mixed results on the effect of MI on smoking cessation used abstinence as the outcome 
variables. The limited efficacy of MI could be explained by the fact that MI represents a style of 
treatment rather than a cessation treatment per se and could indicate that an MI style may not be 
sufficient to help individuals quit smoking. However, given that MI’s purpose is to increase 
motivation to initiate behavior change, this style of treatment could move smokers into more 
intensive and efficacious treatments. 
Studies examining treatment adherence and utilization of smoking cessation services as 
the primary outcomes show some promising results, especially those recruiting difficult-to-treat 
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populations. For instance, a study aimed at motivating smokers with schizophrenia to seek 
treatment for smoking cessation found that MI increased treatment-seeking behavior compared 
to psychoeducational and minimal-control conditions (Steinberg, Ziedonis, Krejci, & Brandon, 
2004). Other studies have shown MI to lead to higher follow-up session attendance among 
smokers with psychosis and high impulsivity (Baker, Richmond, Haile, Lewin, Carr, et al., 2006; 
Helstrom, Hutchison, & Bryan, 2007), as well as a higher likelihood of following through with 
after care treatment among smokers with psychiatric and substance-use disorders (Daley & 
Zuckoff, 1998; Martino, Carroll, O'Malley, & Rounsaville, 2000; Swanson, Pantalon, & Cohen, 
1999).  
The mechanisms of change of MI are not yet fully understood. The research in this area is 
limited and mixed because the majority of studies focused on outcomes rather than process 
(Copeland, McNamara, Kelson, & Simpson, 2015). Some studies suggest that MI is more 
efficacious among those with high impulsivity (Helstrom et al., 2007) and lower motivation to 
change (Brown, Ramsey, Strong, Myers, Lejuez, et al., 2003; Miller & Rollnick, 2002; Rollnick 
et al., 2008). Whereas some research suggests that MI leads to smoking cessation through its 
effects on self-efficacy to quit smoking (Brown et al., 2003), others have failed to find similar 
results (Copeland et al., 2015). More research is needed to understand the mechanisms of change 
of MI.  
The Current Study 
 As reviewed earlier, a large number of veterans are diagnosed with mental illness and/or 
substance use disorders. Also, the majority of these individuals are smokers. Over the years, the 
VA has implemented empirically-based treatments for smoking cessation. These services, 
however, are underutilized. Research examining the efficacy of MI on smoking cessation 
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outcomes, such as abstinence rates, has shown mixed results. However, there is some promising 
evidence suggesting that MI could be used to motivate smokers to seek treatment. The purpose 
of this initial study was to test a MI intervention to motivate veteran smokers undergoing 
treatment for substance use to seek smoking cessation services.  
Primary Aims 
Specific Aim 1: To test the effect of a MI intervention on smoking cessation treatment-
seeking behavior among veterans undergoing substance use treatment at a VA Medical 
Center. 
 Hypothesis 1: Participants randomized to a motivational interviewing condition would 
be more likely to seek smoking cessation services offered at the VA (Nicotine Replacement 
Therapy [NRT], other cessation medication, individual treatment, or group treatment) as a result 
of the MI intervention compared to the control condition. The primary outcome of the study was 
treatment-seeking behavior rather than smoking cessation per se.  
Secondary Aims 
Aim 2: To examine moderators of the effect of MI on smoking cessation treatment-seeking 
behavior.  
 Hypothesis 2: The effect of the MI intervention on smoking cessation treatment-seeking 
behavior would be moderated by baseline motivation, impulsivity, treatment expectancies, and 
baseline self-efficacy. We expected the treatment effect to be larger among participants with 
lower baseline motivation, higher impulsivity, low treatment expectancies (how helpful 
treatment can be and whether smoking cessation treatment could interfere with substance/alcohol 
use treatment), and lower self-efficacy for quitting smoking. 
 
 
 
10 
 
Aim 3: To test mediators of the effect of MI on smoking cessation treatment-seeking 
behavior. 
 Hypothesis 3: The effect of the MI intervention on smoking cessation treatment-seeking 
behavior would be mediated by changes in motivation, self-efficacy, and treatment expectancies. 
Participants who report the highest changes in motivation, self-efficacy, and treatment 
expectancies as a result of the MI intervention should be more likely to seek smoking cessation 
treatment.  
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Method 
 
Experimental Design 
 The study was conducted using a two-group between-subjects design. It was publicized 
as a single session research study designed to compare different ways of discussing smoking 
cessation with VA patients. All recruited participants signed consent. After they consented, 
participants were screened for eligibility criteria. Those who did not meet criteria discontinued 
the study at this point. Eligible participants completed baseline assessments measuring nicotine 
dependence, smoking history and status, demographic information, motivation to smoke, self-
efficacy to quit smoking, impulsivity, and treatment expectancies. Once baseline measures were 
completed, participants were randomized to one of two groups: motivational interviewing or 
active control. After the intervention sessions, participants completed measures of motivation to 
quit smoking, self-efficacy to quit smoking, treatment expectancies, and treatment fidelity, and 
they were compensated for their time. A chart review was conducted by the experimenter to 
collect information about treatment-seeking behavior, psychiatric diagnosis, substance use 
disorder, and smoking-related illness. The study was approved by the local VA Research and 
Development office and University Institutional Review Board. 
Participants 
Participants were 61 (57 males) current veteran smokers recruited from the Substance 
Use Disorder’s Clinic/Intensive Outpatient Program (SUDs/IOP) at the James A. Haley Veterans 
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Hospital. SUDs/IOP is a program that offers outpatient comprehensive care to veterans with 
substance use disorders. A priori power analyses demonstrated that a sample size of 60 (30 
participants per condition) would provide a power of .80 with a two-tailed alpha level of .05 to 
show a medium effect size for the primary aim, Specific Aim 1. The power analysis was 
computed based on results from similar prior research (Daley et al., 1998; Martin et al., 1999; 
Steinberg et al., 2006; Martin et al., 2000), which found approximately 30 percentage points 
difference between the two conditions. Anecdotal reports from the SUDs/IOP program indicated 
that spontaneous rate of smoking cessation treatment-seeking behavior was about 10%. We 
considered the results from these past studies and the baseline treatment-seeking behavior (10%) 
from patients at SUDs/IOP to calculate the sample size. Thus, we used .1 (control group) and .4 
(MI group) as the estimated proportions.  
To participate in the study, participants had to meet the following inclusion criteria: 1) 
veteran, 2) able to read and understand English, 3) 18 to 70 years of age, 4) ≥ 5 cigarettes 
smoked per day for the past year, 5) have an exhaled carbon monoxide (CO) of 5 ppm or greater, 
and 6) not currently enrolled in any formal smoking cessation treatment or support group. 
Participants received $25 for their approximately 1.5-hour participation in the study.  
Measures 
 Screening Form. Eligibility screening was conducted in person. A screening form was 
used during the initial contact with participants. 
 Demographic Form. The demographic form was used to gather information regarding 
participants’ gender, age, date of birth, education level, occupation, employment status, ethnicity, 
racial identity, and marital status. 
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 Exhaled Carbon Monoxide. Carbon monoxide (CO) level was assessed at baseline to 
obtain a biochemical verification of smoking status. The cutoff for eligibility was 5 ppm or 
greater (e.g., Deveci, Deveci, Açik, & Ozan, 2004; Perkins, Karelitz, & Jao, 2013). 
Smoking Status Form. The Smoking Status Form (SSF) assessed current smoking status 
and smoking history. The Fagerström Test for Nicotine Dependence (FTND; Heatherton, 
Kozlowski, Frecker, & Fagerström, 1991) was included in the SSF as a measure of nicotine 
dependence.  
 Motivation. The Contemplation Ladder (Biener & Abrams, 1991) is a measure that 
assesses current motivation to quit smoking. This measure depicts a ladder that represents a 
continuum of readiness to quit smoking, ranging from 0 (No thought of quitting) to 10 (Taking 
action to quit). This measure has demonstrated good predictive validity, such that it predicts 
future quit attempts and likelihood to take action to quit (Biener & Abrams, 1991). Participants 
were also asked to rate their motivation to quit, on a 10-point rating scale, using a single item 
(How committed are you to quit smoking?). We also asked participants about their motivation to 
seek help to quit smoking using the same 10-point rating scale format. 
Treatment Expectancies. Treatment expectancies were assessed with a 3-item measure 
assessing participants’ beliefs about the benefits of smoking cessation treatment and whether 
they believe that smoking cessation treatment could interfere with their substance and alcohol 
use treatment. Participants were asked to answer each item on a 7-point Likert Scale. Baseline 
expectancies were explored as possible moderators of the effect of the MI intervention on 
treatment-seeking behavior 
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 Self-efficacy. Self-efficacy to quit smoking was assessed using a single item asking 
participants to rate, on a scale from 1 (not at all) to 10 (very), how confident they were about 
their ability to quit smoking. We also asked about self-efficacy to seek help quitting smoking.  
 Barratt Impulsiveness Scale. The Barratt Impulsiveness Scale (BIS-11; Patton, 
Stanford, & Barratt, 1995) is a 34-item self-report measure of trait impulsivity. Participants were 
asked to rate, on a scale from 1 (Rarely/Never) to 4 (Almost Always/Always), how they act and 
think in different contexts. Impulsivity was explored as a possible moderator of the effect of the 
MI intervention on treatment-seeking behavior. 
Motivational Interviewing Treatment Integrity Scale.  The Motivational Interviewing 
Treatment Integrity scale (MITI; Moyers, Martin, Manuel, Hendrickson, & Miller, 2005) was 
used to measure treatment fidelity. A random sample of 10 audiotapes from each condition was 
selected. The therapist’s supervisor, who was blind to condition, rated the therapist on a 7-point 
Liker scale, on empathy, MI spirit, giving information, MI adherent behaviors, reflections, and 
open questions. Higher scores indicated higher levels on the two constructs. A patient report of 
topics covered during the session was added as a secondary measure of fidelity. 
Mental Illness. The experimenter collected information about psychiatric diagnosis, 
substance use disorder, psychiatric medication, and medical conditions through chart review. 
This information was recorded in the Psychiatric Diagnoses Record Form. 
Treatment-Seeking Behavior. Treatment-seeking behavior was operationalized as 
action from the patient to request smoking cessation treatment (NRT, other medication, 
individual or group counseling) from psychiatrists, nurses, and psychologists at SUDS/IOP. 
Patients at the VA can request a prescription for nicotine replacement therapy at no cost. The VA 
also offers a manualized and empirically-based individual smoking cessation treatment based on 
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Cognitive Behavioral Therapy. At the VA, all patient and provider contact is recorded in the 
patient’s medical chart. The experimenter reviewed the patient’s medical record at the end of 
their substance use treatment (2 to 5 weeks after the study intervention) to collect information 
about smoking cessation services requested by the participant. At the end of the intervention, 
participants were provided a handout describing the services available to them and how to get 
them. The contact information of the staff psychologist who provides smoking cessation 
counseling at the outpatient clinic was added in the handout. Participants were asked to contact 
her to schedule an appointment for smoking cessation counseling. She assisted with tracking of 
all individuals who request services for smoking cessation through her. All SUDs/IOP patients 
completed an exit interview upon completion of the outpatient substance use program.  
Questions about quit attempts and use of e-cigarettes to aid smoking cessation were added to the 
exit interview. 
Procedures 
Recruitment. Recruitment of participants occurred during a weekly tobacco recovery 
education class, which is required as part of the program to all enrollees, including nonsmokers. 
Enrollees attend this class while they participate in the program. The class is led by different 
providers, and the number of classes attended by each patient varies. In addition, patients may 
enroll in SUDS/IOP several times as they relapse, which means that they could repeat the 
nicotine recovery education class several times. During the nicotine recovery class, patients are 
informed about quit aids (what is available and what they are), and they discuss triggers to 
smoke, reasons to quit smoking, and barriers to quitting smoking. In addition, they are informed 
about the smoking cessation services offered at the clinic. This education class is conducted in a 
group, lecture format by different providers, and it does not follow any particular protocol or 
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schedule. The content of the class may include some aspects of cognitive behavioral therapy 
(discussing barriers to quit and triggers for smoking) and motivational interviewing (discussing 
reasons to quit smoking). This class posed several challenges to the study.  First, the variability 
in class topics, providers, content, and attendance introduced error variance that could have made 
it more difficult to find significant differences between the conditions. Second, whereas the goal 
of the study was to motivate patients to seek smoking cessation treatment, this class could be 
conceptualized as a similar program that all participants already received to some degree.  
However, was largely ineffective as such, and it historically has not resulted in more than 10% of 
participants seeking additional smoking cessation assistance. Thus, there was sufficient room for 
improvement via the interventions tested in the present study.   
The experimenter attended the weekly tobacco recovery education class to make veterans 
aware of the study. Interested participants were able to schedule an appointment with the 
experimenter at the end of the class. 
Consent. Before screening for eligibility criteria and the experimental procedures, the 
experimenter explained the study’s procedures and purposes to the participants. The 
experimenter went through a consent form with the participants, in which their rights as human 
research participants were described. Participants were asked to sign the informed consent and a 
HIPAA form upon agreeing to participate in the study. 
 Screening. Consented participants were screened for eligibility. The Screening Form was 
completed with participants. In addition, participants were asked to provide a breath sample to 
measure CO levels to verify smoking status. Participants who did not meet eligibility criteria 
discontinued the study at this point. 
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 Baseline Measures. Eligible participants were asked to complete baseline measures. 
These included the demographic form, smoking status form, Contemplation Ladder (baseline 
motivation), baseline self-efficacy to quit smoking, impulsivity, and treatment expectancies. 
 Randomization. After completion of the baseline questionnaires, participants were 
randomized (using www.randomizer.org) to one of two conditions: 1) motivational interviewing, 
or 2) health education control.  
 Intervention. After randomization, participants underwent an intervention (MI or health 
education control). The intervention occurred within the first 2 weeks of participant recruitment 
(the first or second week of substance use treatment). Participants underwent an MI or Health 
Education intervention that lasted approximately 40 minutes.  
 Post-intervention measures. After the intervention, participants were asked to complete 
measures that assessed motivation to quit smoking, self-efficacy, and treatment expectancies. 
Follow-up. The experimenter collected information about treatment seeking behavior 
through chart review at the end of the substance use treatment. 
Interventions 
Training and treatment fidelity. The experimenter received training from experienced 
MI trainers, who are affiliated with The Motivational Interviewing Network of Trainers (MINT). 
The experimenter received 20 hours of training. Supervision was provided by an experienced 
clinician once per week and as needed throughout the recruitment process.  As described earlier, 
the supervisor blindly completed the MITI using 10 audiotapes selected at random from each 
condition. 
 MI. The MI intervention was based on the concepts outlined by Miller and Rollnick 
(1991, 2002, 2008, 2009). MI is not an intervention or treatment modality per se; rather, MI can 
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be described as a person-centered, therapeutic or collaborative conversation style that is intended 
to build up an individual’s motivation and commitment to change (Miller & Rollnick, 2008, 
2009). MI’s primary goal is to address an individual’s ambivalence about behavior change. MI 
intends to engage a person in a conversation about problematic behavior while expressing 
empathy, eliciting ambivalence, rolling with resistance, and increasing self-efficacy to change 
(Miller & Rollnick, 2002). The role of a therapist that uses MI is to assist individuals verbalize 
discrepancies between their behavior and goals and resolve them (Miller & Rollnick, 2002). The 
purpose of our sessions was consistent with the MI spirit, which includes expressing empathy, 
eliciting ambivalence, rolling with resistance, and increasing self-efficacy to quit smoking 
(Miller & Rollnick, 2002). The intervention lasted approximately 40 minutes and concluded with 
information about the smoking cessation resources that are available at the outpatient substance 
use clinic.  
Health Education Control. Participants in the control condition completed baseline 
measures and underwent a smoking history interview. The Smoking Status Form was used to 
guide the interview. The interview consisted of asking participants questions about their 
experience with cigarette smoking, maintenance of smoking, quit attempts, and family history of 
cigarette smoking. In addition, the intervention included educational information about smoking-
related illnesses. The experimenter presented information about prevalence and etiology of 
several diseases that are a direct consequence of smoking cigarettes, such as multiple cancers, 
cardiovascular disease, diabetes, respiratory illnesses, stroke, and hypertension. Participants were 
allowed to share and discuss concerns about smoking in ways that relate to their health. The 
intervention concluded with information about the smoking cessation resources that are available 
at the outpatient substance use clinic. Previous studies have shown this type of intervention to be 
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credible and helpful to smokers undergoing treatment for smoking cessation (Webb, de Ybarra, 
Baker, Reis, & Carey, 2010). The health education control intervention lasted approximately 40 
minutes, matching the MI intervention.  
 The length of the interventions (minutes) were recorded to assure that there were no 
significant differences in contact time between the two conditions. Participants in both 
conditions completed the same protocol (same measures in the same order) and only the content 
of the interventions differed.  
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Results 
 
Demographics Characteristics 
Figure 1 shows the study’s recruitment progression from screening to completion of 
study session. Out of 68 consented participants, 61 met eligibility criteria and 7 failed screening. 
The 7 consented individuals who failed screening smoked fewer than 5 cigarettes per day and 
had a breath CO level below 5 ppm. The data from one consented and eligible participant were 
excluded from analyses due to a non-study related hospitalization one week after completing the 
study session; thus, outcome data were not available for this participant. Analyses were 
conducted with data from 60 eligible participants. 
 Baseline demographic characteristics and smoking-related variables for the two groups 
were compared using Chi-square for categorical variables and independent-t tests for continuous 
variables (see Table 1).  Between-group baseline differences were found on ethnicity (p = .02), 
FTND (p = .04), and baseline motivation to quit smoking (p = .08).  Regression analyses were 
conducted to test whether these variables predicted the outcome. Only baseline motivation to quit 
smoking predicted treatment seeking behavior post-intervention β = .29, p = .02; therefore, it was 
included in the primary analyses as a covariate.  
Specific Aim 1 
We predicted that individuals in the MI condition would be more likely to engage in 
smoking cessation treatment compared to those in the control condition. Overall, 31.67% (n = 
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19) participants sought treatment after the intervention and 68.33 % (41) did not. In the MI 
condition, 40% (n = 12) of participants sought treatment for smoking cessation following the 
intervention, compared to 23.3% (n = 7) of participants in the control condition. A logistic 
regression was conducted to test the effect of the intervention on smoking cessation treatment-
seeking behavior with and without baseline motivation to quit smoking entered in the model as a 
covariate. When entering condition alone in the logistic regression model, the results showed that 
condition was not predictive of the outcome, β = .78, Wald X2 (1) = 1.89, p = .17, OR = 2.19, 
95% CI [.72, 6.70]. However, after controlling for baseline motivation to quit smoking, condition 
significantly predicted the outcome, β = 1.47, Wald X2 (1) = 4.54, p = .03, OR = 4.34, 95% CI 
[CI = 1.13, 16.72], such that individuals in the MI condition were more likely to seek treatment 
to quit smoking than individuals in the health education control condition.  
Table 2 shows the type of treatment sought by participants by group. A chi-square test for 
independence, with Fisher’s exact correction, was conducted to examine preference of treatment 
between the groups. There were no significant differences between conditions on type of 
treatment sought, X2 (1, n = 30) = 3.74, p = .50. A chi-test goodness of test was conducted within 
each group to determine whether at least one type of treatment was preferred over the others. 
These tests were corrected using the Fisher’s Exact method, given that some of the cells had 
fewer than five cases. The chi-square goodness of fit test for the MI group showed that at least 
one type of treatment was preferred over the others, X2 (3, N = 30) = 8.00, p = .046. However, 
follow-up, pair-wise comparison tests showed that individuals in the MI condition showed a non-
significant preference for NRT over medications, X2 (1, N = 30) = 4.50, p = .07, or combination 
therapy, X2 (1, N = 30) = 4.50, p = .07. A similar analysis was conducted to assess whether 
smokers in the control condition prefer at least one type of treatment over the others. The chi-
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square goodness of fit test for the control condition indicated that there was no significant 
difference in the type of treatment in which smokers in the health education condition engaged, 
X2 (2, N = 30) = .29, p = .10.  
Secondary Aim 2  
Motivation to Quit Smoking. We predicted that the effect of the intervention on 
smoking cessation treatment-seeking behavior would be moderated by baseline motivation to 
quit smoking, such that the treatment effect would be larger among participants with lower 
baseline motivation to quit smoking. To test this hypothesis, we implemented a logistic 
regression analysis by entering baseline motivation to quit smoking, condition, and the 
interaction term between these two variables in the model. The logistic regression showed a main 
effect of baseline motivation to quit smoking, β = 2.51, Wald X2 (1) = 4.425, p = .02, OR = 
12.27, 95% CI [1.19, 126.75], a main effect of Condition, β = 3.80, Wald X2 (1) = 4.98, p = .03, 
OR = 44.78, 95% CI [1.59, 1263.52], and a trending interaction, β = -1.15, Wald X2 (1) = 3.59, p 
= .06, OR = .32, 95% CI [.10, 1.04]. To follow up, we dichotomized baseline motivation to quit 
smoking using a median split (Median = 5.50) and plotted the effect of the condition on seeking 
treatment to quit smoking by baseline motivation level (high and low). See Figure 2. 
As predicted, these findings suggest that among individuals with low baseline motivation 
to quit smoking, the MI intervention had the greatest effect on treatment-seeking behavior, X2 (1, 
n = 30) = 5.46, p = .02. Indeed, only in the MI condition did any individuals with low baseline 
motivation end up seeking treatment.  Although this figure also suggests that health education 
had a greater effect among participants with high baseline motivation to quit smoking, this 
difference was not statistically significant, X2 (1, n = 30) = .72, p = .79.  
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Self-efficacy to Quit Smoking. We predicted that the effect of the intervention on 
smoking cessation treatment-seeking behavior would be moderated by baseline self-efficacy to 
quit smoking, such that the treatment effect would be larger among participants with lower 
baseline self-efficacy to quit smoking. We conducted a logistic regression, with and without 
baseline motivation to quit smoking entered in the model as a covariate, to test our hypothesis. 
When baseline motivation to quit smoking was entered in the model, we found a main effect of 
condition, β = 1.69, Wald X2 (1) = 4.66, p = .03, OR = 5.42, 95% CI [1.17, 25.12], but failed to 
find a main effect of baseline self-efficacy to quit smoking, β = .39, Wald X2 (1) = .62, p = .43, 
OR =1.47, 95% CI [.56, 3.85], or an interaction between baseline self-efficacy to quit smoking 
and condition, β = -2.12, Wald X2 (1) = .57, p = .45, OR = .81, 95% CI [.47, 1.40]. When 
baseline motivation to quit smoking was not included as a covariate in the model, we failed to 
find a main effect of condition, β = 1.25, Wald X2 (1) = 3.24, p = .07, OR = 3.50, 95% CI [.90, 
13.66], a main effect of baseline self-efficacy to quit smoking, β = .52, Wald X2 (1) = 1.26, p = 
.26, OR = 1.69, 95% CI [.68, 4.19], or a significant interaction, β = -.17, Wald X2 (1) = .431, p = 
.51, OR = .84, 95% CI [.50, 1.41]. Thus, our hypothesis that baseline self-efficacy to quit 
smoking would moderate the effect of the intervention on treatment-seeking behavior was not 
supported. 
Impulsivity. Based on prior literature, we hypothesized that impulsivity would moderate 
the effect of the intervention on treatment-seeking behavior, such that we expected the treatment 
effect to be larger among participants with higher Impulsivity scores at baseline. We 
implemented a logistic regression to test our hypothesis, with and without baseline motivation to 
quit smoking entered in the model. When baseline motivation to quit smoking was included as a 
covariate in the model, we found a main effect of baseline motivation to quit smoking, β = .37, 
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Wald X2 (1) = 6.76, p = .01, OR = 1.45, 95% CI [1.10, 1.91], a main effect of condition, β = 1.56, 
Wald X2 (1) = 4.94, p = .03, OR = 4.74, 95% CI [1.10, 18.71], but failed to find a main effect of 
Impulsivity, β = -.05, Wald X2 (1) = .35, p = .56, OR = .95, 95% CI [.81, 1.12], or an interaction 
between Impulsivity and Condition, β = .03, Wald X2 (1) = .37, p = .54, OR = 1.03, 95% CI [.93, 
1.14]. When baseline motivation to quit smoking was excluded from the model, we failed to find 
a main effect of condition, β = .94, Wald X2 (1) = 2.53, p = .11, OR = 2.57, 95% CI [.80, 8.23], a 
main effect of Impulsivity, β = -.02, Wald X2 (1) = .10, p = .75, OR = .98, 95% CI [.84, 1.13], or 
an interaction between the two, β = 0.15, Wald X2 (1) = .11, p = .74, OR = .10, 95% CI [.93, 
1.11].  These findings do not support our hypothesis that Impulsivity would moderate the effect 
of the intervention on the outcome. 
Treatment Expectancies. This study included three items about treatment expectancies, 
which were measured before and after the intervention. These items were: 1) Quitting smoking 
will help me become free of drugs and alcohol (Expectancy 1), 2) Quitting smoking will lead me 
to relapse from substance/alcohol use (Expectancy 2), and 3) Counseling for smoking cessation 
at the VA can help me quit smoking (Expectancy 3). Baseline and post-intervention means and 
standard deviations are shown in Table 3. 
Logistic regression analyses were conducted to examine the ability of baseline Treatment 
Expectancies to moderate the effect of the intervention on smoking cessation treatment-seeking 
behavior. We conducted these analyses with and without baseline motivation to quit smoking as 
a covariate. We expected the effect of the intervention to be greater among individuals with 
lower scores on the Treatment Expectancies at baseline. The findings show that baseline 
treatment expectancies did not moderate the effect of the intervention on the study outcome. The 
results remained the same when baseline motivation to quit smoking was excluded from the 
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logistic regression model. Results (including baseline motivation to quit smoking as a covariate) 
are presented in Table 4. 
Secondary Aim 3 
We hypothesize that the effect of the MI intervention on smoking cessation treatment-
seeking behavior would be mediated by the changes in motivation and self-efficacy, such that we 
expect that participants who report the highest changes in motivation and self-efficacy as a result 
of the MI intervention will be more likely to seek smoking cessation treatment.  
Motivation Change.  Prior to conducting the mediation analysis to test the ability of 
motivation change to predict the effect of the intervention, we explored changes in motivation as 
a result of the intervention. Table 5 shows the means and standard deviations for baseline and 
post-intervention motivation to quit smoking per condition.  
 We conducted a Repeated Measures ANOVA to examine the effects of time, condition, 
and the interaction between the two. This analysis yielded a significant main effect only for 
Time, F (1, 58) = 36.68, p < .01, but no main effect of condition, F (1, 58) = 1.59, p = 2.13, or 
time by condition interaction, F (1, 58) = 2.62, p = .11. These results suggest that motivation to 
quit smoking increased significantly from baseline to post-intervention, regardless of condition. 
Given that the groups did not differ in motivational change, mediation effects were 
unlikely.  Nevertheless, we conducted a mediation analysis using the bootstrapping procedure via 
the PROCESS macro developed by Hayes (2013) to explore the ability of motivation to quit 
smoking to mediate the relationship between condition and outcome. Baseline motivation to quit 
smoking was included in the mediation models as a covariate. Although the effect of condition 
on treatment-seeking behavior was significant, b = 1.48, SE = .69, p = .03 (path c), neither the 
effect of condition on motivation change, (path a), b = .56, SE = .54, p = .31, nor the effect of 
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motivation change on treatment seeking, (path b), b = .17, SE .18, p = .34, were significant.  
Moreover, the model showed that condition remained a significant predictor of treatment-seeking 
behavior when motivation change was entered in the model (c’) b = 1.37, SE = .70, p = .05.  
Thus, these results do not support mediation by motivation change.  
Self-efficacy Change. Prior to conducting the mediation analysis to test the ability of 
self-efficacy change to predict the effect of the intervention, we explored changes in self-efficacy 
in the context of the intervention. We conducted a Repeated Measures ANCOVA. Baseline 
motivation to quit smoking was included in the model as a covariate. This analysis yielded a 
significant effect of time, F (1, 57) = 7.54, p = .01. We failed to find a significant effect of 
condition, F (1, 57) = .00, p = .99, or interaction between condition and time, F (1, 57) = 1.60, p 
= .21. These results suggest that self-efficacy to quit smoking scores increased significantly from 
baseline to post-intervention, regardless of condition. 
A similar mediation analysis approach was used to explore the ability of self-efficacy 
change to mediate the relationship between condition and outcome. Although the effect of 
condition on treatment-seeking behavior was significant, b = 1.48, SE = .69, p = .03 (path c), 
neither the effect of condition on self-efficacy change (path a), b = .69, SE = .54, p = .21, nor the 
effect of self-efficacy change on treatment-seeking behavior (path b), b = .18, SE = .16, p = .25, 
were significant. In addition, the model showed that condition remained a significant predictor of 
treatment-seeking behavior when self-efficacy change was entered in the model (c`), b = 1.36, 
SE = .70, p = .05. These findings do not support mediation by self-efficacy change. 
A similar mediation analysis was used to explore the ability of treatment expectancy 
change to mediate the relationship between condition and outcome. The mediation model that 
included treatment expectancy 1 as a mediator showed that although the effect of condition on 
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treatment-seeking behavior was significant, b = 1.48, SE = .69, p = .03 (path c), neither the effect 
the effect of condition on expectancy change 1 (path a), b = .15, SE = .25, p = .57, nor the effect 
of self-expectancy change 1 on treatment-seeking behavior (path b), b = .08, SE = .33, p = .81, 
were significant. In addition, the model showed that condition remained a significant predictor of 
treatment-seeking behavior when self-efficacy change was entered in the model (c`), b = 1.46, 
SE = .69, p = .03. These findings do not support mediation by expectancy 1 change. 
The mediation model with treatment expectancy 2 change included as a mediator showed 
a significant effect of condition on treatment-seeking behavior was significant (path c), b = 1.49, 
SE = .69, p = .03 (path c). However, neither the effect of condition on expectancy 2 change (path 
a), b = -.02, SE = .25, p = .92, nor the effect of self-expectancy 2 change on treatment-seeking 
behavior (path b), b = .20, SE = .32, p = .52, were significant. Furthermore, condition remained a 
significantly predictor of treatment-seeking behavior, b = 1.48, SE = .69, p = .03 (c`), when 
treatment expectancy change 2 was entered in the model. These findings do not support 
mediation by expectancy 2 change. 
The mediation model with treatment expectancy 3 change included as a mediator showed 
a significant effect of condition on treatment-seeking behavior was significant (path c), b = 1.52, 
SE = .71, p = .03. However, neither the effect of condition on expectancy 3 change (path a), b = -
.48, SE = .32, p = .14, nor the effect of self-expectancy 3 change on treatment-seeking behavior 
(path b), b = .08, SE = .27, p = .76, were significant. Furthermore, condition remained a 
significantly predictor of treatment-seeking behavior, b = 1.51, SE = .71, p = .03 (c`), when 
treatment expectancy 3 change was entered in the model. These findings do not support 
mediation by expectancy 3 change. 
Exploratory Analyses 
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 During chart review, we collected information on the participants’ number of co-morbid 
psychiatric diagnoses, number of medical conditions, number of psychotropic medications, and 
number of medications prescribed for medical needs. We explored whether the intervention’s 
effectiveness differed depending on the psychological and health presentation of participants. 
First, we tested whether the two conditions differed in these variables at baseline by conducting 
an Independent Samples t-tests. See Table 6. The groups were indistinguishable in number of 
co-morbid psychiatric diagnoses, number of psychotropic medications, number of medical 
conditions, and number of medications for medical conditions at baseline. Then, we calculated 
the phi coefficient between the outcome--treatment-seeking behavior--and the variables 
mentioned above. See Table 7. We found that treatment-seeking behavior was significantly 
related to number of medical conditions and number of medications taken for these conditions.  
 We also explored whether the effect of the intervention on the outcome was moderated 
by number of psychiatric diagnoses, number of medical conditions, number of psychotropic 
medications, or number of medications. We conducted a logistic regression to explore the latter, 
which did not reveal significant interactions between condition and any of these variables. 
Taken together, these exploratory analyses suggest that participants with a larger number of 
medical diagnoses and who are prescribed a larger number of medications to treat these 
conditions are more likely to engage in smoking cessation treatment, independent of type of 
intervention. 
 
Treatment Fidelity 
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Our intention was to match the two conditions on session length.  As expected, length of 
session (minutes) did not significantly differ between the MI (M = 35.14, SD = 5.64) and Health 
Education (M = 38.00, SD = 7.42) conditions, t (56) = 1.64, p = .11. 
We used two methods to assess treatment integrity. The first method consisted of a 
patient self-report measure of topics covered during the session. Items 1 – 10 included topics 
covered during the MI session and items 11 – 18 included topics covered during the Health 
Education Control session.  The supervisor – blind to condition - also rated the therapist, on 7-
point Liker scales, on empathy, MI spirit, giving information, MI adherent behaviors, 
reflections, and open questions. Higher scores on MI recordings indicated higher levels of 
adherence to the MI spirit, whereas lower scores on the Control recordings indicated lower 
levels of adherence to the MI spirit in that condition.  
 Independent t-tests were conducted to examine differences between groups on the self-
report measure of topics covered during the session.  The first t-test showed that participants in 
the MI condition (M = 9.14, SD = 1.22) endorsed items consistent with the MI session 
significantly more than participants in the control group (M = 8.00, SD = 1.67), t (58) = -2.97, p 
< .01. The second t-test showed that participants in the control condition (M = 5.07, SD = 1.20) 
endorsed items consistent with the control session significantly more than participants in the MI 
condition (M = 2.57, SD = 1.94), t (58) = -2.97, p < .01. Analysis of the supervisor rated audio 
recordings revealed a significant difference in MI spirit adherence between the MI (M = 27.40, 
SD = 4.20) and Health Education (M = 17.70, SD = 1.42) conditions, t (18) = -6.93, p < .01, 
suggesting higher adherence to the MI spirit when conducting the MI intervention. 
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Table 1  
Demographic Characteristics and Smoking Variables of Participants at Baseline for Full Sample 
and by Condition (N = 60) 
Variable MI 
Condition 
n (%) 
Control Condition 
n (%) 
p 
Age (M, SD) 50.17 
(11.96) 
48.30 (11.75) .54 
Male  28 (93.3) 29 (96.7) .55 
Race 
     American Indian/Alaskan Native 
     Asian 
     Native Hawaiian/Other Pacific Islander 
     African American 
     Caucasian 
 
1 (3.3) 
0 
0 
17 (56.7) 
12 (40.0) 
 
0 
1 (3.3) 
0 
12 (40.0) 
17 (56.7) 
 
.29 
Hispanic 0 5 (16.7) .02* 
Marital Status 
     Single 
     Married 
     Separated 
     Divorced 
     Widowed 
 
11 (36.7) 
7 (23.3) 
5 (16.7) 
7 (23.3) 
0 
 
10 (33.3) 
2 (6.7) 
8 (26.7) 
8 (26.7) 
2 (6.7) 
 
.23 
Income 
     Under $10,000 
     $10,000 - $19,000 
     $20,000 – $29,000 
     $30,000 – $39,000 
     $40,000 – $49,000 
     $50,000 – $59,000 
     $60,000 – $69,000 
     $70,000 – $79,000 
     $80,000 – $89,000 
     Over $90,000 
 
16 (53.3) 
7 (23.3) 
2 (6.7) 
0 
2 (6.7) 
1 (3.3) 
0 
1 (3.3) 
0 
1 (3.3) 
 
13 (43.3) 
8 (26.7) 
4 (13.3) 
1 (3.3) 
1 (3.3) 
1 (3.3) 
0 
0 
2 (6.7) 
0 
 
.61 
Education 
     Did not graduate HS 
     High school graduate 
     Some college 
     Technical school/Associates  
     4-year college  
     Some school beyond 4-year college 
     Professional degree (MD, JD, PhD) 
 
0 
11 (36.7) 
11 (36.7) 
4 (13.3) 
1 (3.3) 
3 (10) 
0 
 
2 (6.7) 
4 (13.3) 
15 (50.0) 
7 (23.3) 
1 (3.3) 
1 (3.3) 
0 
 
.17 
CPD (M, SD) 17.7 (9.68) 16.43 (7.62)      .58 
FTND (M, SD) 4.33 (1.06) 3.733 (1.17) .04* 
Years Smoking (M, SD) 30.63 
(14.95) 
29.05 (14.75) .68 
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Note: HS = High School; MD = Medical Doctor; JD = Juris Doctor; Ph.D. = Doctor in 
Philosophy; CPD = Cigarettes Per Day; FTND = Fagerstrom Test for Nicotine Dependence; CO 
= Carbon Monoxide Level (ppm); The Contemplation Ladder was used to measure Baseline 
Motivation to Quit Smoking; Impulsivity was measured using the Barratt Impulsivity Scale; 
Self-efficacy to Quit Smoking was measured with a single item asking participants to rate how 
confident they are about their ability to quit smoking; Expectancies for treatment were measured 
with three items assessing whether they believe that smoking cessation treatment could interfere 
with their substance and alcohol use treatment and whether they think the VA could help them 
quit smoking. 
  
Table 1 (Continued)    
Variable MI 
Condition 
n (%) 
Control Condition 
n (%) 
p 
    
CO (M, SD) 29.93 
(16.30) 
28.23 (12.79) .66 
Baseline Motivation to Quit Smoking (M, SD) 4.97 (2.92) 6.30 (2.87) .08 
Baseline Self-efficacy to Quit Smoking (M, 
SD) 
4.90 (2.78) 6.00 (2.63) .12 
Impulsivity (M, SD) 69.43 
(13.60) 
68.59 (12.95) .81 
Expectancy 1 (M, SD) 3.07 (1.55) 3.10 (1.58) .94 
Expectancy 2 (M, SD) 1.43 (1.01) 1.50 (0.93) .79 
Expectancy 3 (M, SD) 3.57 (1.19) 3.63 (0.99) .82 
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Table 2   
Type of Treatment Sought by Participants by Condition 
Type of Treatment MI Health Education Control 
Counseling 3 2 
NRT 7 3 
Medication 1 0 
Combination Therapy 1 2 
Note: NRT = Nicotine Replacement Therapy; Medication = Buproprion or Chantix; Combination Therapy = 
Counseling + Medication 
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Table 3 
Means and Standard Deviations for Baseline and Post-Intervention Treatment Expectancies by 
Condition 
                           Baseline Post-Intervention 
 MI Control p MI Control p 
Expectancy 1 3.07 (1.55) 3.10 (1.58) .94 3.43 (1.61) 3.33 (1.67) .81 
Expectancy 2 1.43 (1.01) 1.50 (0.93) .79 1.40 (.894) 1.47 (0.90) .77 
Expectancy 3 3.57 (1.19) 3.63 (0.99) .82 3.97 (1.38) 4.50 (0.78) .07 
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Table 4 
Summary of Logistic Regression Analysis for Treatment Expectancies Predicting Treatment-
Seeking Behavior while Controlling for Baseline Motivation to Quit Smoking 
 
Predictor B SE B eB 
Expectancy 1    
       Baseline Motivation .39** .15 1.47 
       Condition 4.04* 1.92 56.96 
       Expectancy 1 1.23 .81 3.42 
       Condition x Expectancy 1 -.73 .48 .48 
Expectancy 2    
       Baseline Motivation .42** .15 1.52 
       Condition .38 1.19 .75 
       Expectancy 2 -1.18 1.15 .31 
       Condition x Expectancy 2 .81 .74 .25 
Expectancy 3    
       Baseline Motivation .38** .14 1.45 
       Condition 2.31 2.32 10.10 
       Expectancy 3 .40 1.00 1.49 
       Condition x Expectancy 3 -.23 .59 .78 
Note: * p < .05, ** p < .01, * p < .001. 
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Table 5 
Baseline and Post-Intervention Statistics for Motivation to Quit Smoking and Self-Efficacy 
                           Baseline Post-Intervention 
 MI Control p MI Control p 
Motivation to Quit 4.97 (2.92) 6.30 (2.87) .08 7.10 (3.25) 7.53 (2.61) .57 
Self-efficacy 4.90 (2.92) 6.00 (2.63) .12 6.57 (3.20) 6.90 (2.51) .66 
 
  
 
 
36 
 
Table 6 
Baseline Characteristics for Co-Morbid Psychiatric Diagnoses, Psychotropic Medications, 
Medical Conditions, and Medications Taken for Medical Conditions. 
 
 MI Control  
 M (SD) M (SD) p 
Psychiatric diagnoses 2.37 (1.00) 2.63 (1.47) .41 
Psychotropic medications 2.03 (1.56) 2.10 (1.49) .87 
Medical conditions 6.57 (4.47) 6.47 (3.24) .92 
Medications (health) 7.00 (4.43) 5.37 (4.34) .15 
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Table 7 
Correlations Between Outcome and Number of Psychiatric Conditions, Number of Psychotropic 
Medications, Number of Medical Conditions, And Number of Medications for Medical 
Conditions. 
 
 Psychiatric 
diagnoses 
Medical 
conditions 
Psychotropic 
medications 
Medications 
(Health) 
Treatment-seeking Behavior -.015 .273* -.006 .454*** 
Note: * p < .05, ** p < .01, *** p < .001. 
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Figure 1. Participant flow through consent, screening, and enrollment. 
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Figure 2. Effect of intervention on treatment-seeking behavior by baseline motivation to quit smoking. 
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Discussion 
 
 
The present randomized, controlled study provides support for the usefulness of MI in 
engaging veteran cigarette smokers undergoing treatment for substance use in smoking cessation 
treatment.  We found that veteran smokers randomized to the MI condition were more likely to 
engage in smoking cessation treatment compared to veteran smokers randomized to the health 
education condition, when group differences in baseline motivation were accounted for.   There 
was a tendency for veteran smokers in the MI condition to prefer NRT over counseling. This 
observation is consistent with previous studies that have found greater preference for NRT 
among smokers with a history of substance dependence (Cooney, Cooney, Perry, Carbone, 
Cohen et al., 2009).  Although the interaction just missed statistical significance, our results also 
suggest that the MI intervention was most effective among veterans who had low baseline 
motivation to quit smoking.  These results are consistent with MI theory, as this intervention was 
developed to increase motivation among individuals who are ambivalent about behavioral 
change and have low motivation to do so (Miller & Rollnick, 2002).   
Our results are consistent with previous studies that found a significant effect of MI on 
increasing treatment-seeking behavior compared to psychoeducation and treatment-as-usual 
control groups (e.g., Daley et al., 1998; Martino et al., 1999; Steinberg et al., 2004).  A recent 
quasi-experimental pilot study examined the effect of two group MI (tobacco-related vs. general 
substance use-related) interventions on smoking cessation treatment-seeking behavior in a 
sample of homeless veterans seeking treatment for alcohol use in an outpatient clinic (Santa Ana, 
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LaRowe, Armeson, Lamb, & Hartwell, 2016).  That study found that a multi-session, tobacco-
modified version of group MI enhanced motivation to quit smoking and led to significantly 
higher treatment-seeking behavior compared to a group MI condition that focused on general 
abstinence from substances.  In addition, participants in the latter study engaged in the same 
pattern of treatment-seeking behavior as participants in our present study, such that a larger 
number of veterans requested NRT compared to other smoking cessation aids (smoking cessation 
classes or combination of classes and NRT).  One advantage of our study over the previous 
quasi-experimental design is that stronger evidence of causality is provided by the randomized 
design.  It also demonstrated similar results in the context of a brief, individual MI intervention.  
Thus, the efficacy of tobacco-related MI may translate across treatment modalities and across 
treatment lengths.  Our small, randomized-controlled study provides further evidence of the 
utility of MI in engaging veteran smokers undergoing treatment for substance use in treatment 
for smoking cessation.   
Although our study is consistent with previous studies testing the effect of MI on 
smoking-cessation treatment behavior among different populations, these studies did not 
examine the mechanisms of change driving the effect of the intervention on the outcome.  In the 
present study, we were interested in exploring the processes by which our brief MI intervention 
could lead to smoking cessation treatment-seeking behavior.  We hypothesized that changes in 
motivation and self-efficacy would underlie the effect of MI on the study outcome.  This study 
did not provide a clear understanding as to how the brief MI intervention worked, as motivation 
to quit smoking and self-efficacy significantly improved for the entire sample, regardless of 
condition.  Mediation analyses showed that motivation and self-efficacy did not mediate the 
effect of the intervention on the study outcome.  
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One possible explanation for the lack of mediational evidence is that our study was small 
and, as such, was powered to test only the main effect of the intervention (MI vs.  Health 
Education) on smoking cessation treatment-seeking behavior.  Although we were interested in 
exploring the mechanisms of change regarding MI, our study was not powered for mediation 
analyses. Another possible explanation for the lack of mediational evidence is that the measures 
may not have been sensitive enough to detect particular aspects of motivation and self-efficacy 
that may lead individuals to change their behavior. Previous research suggests that motivation, 
for instance, could be a multidimensional and dynamic process (Simmons, Heckman, Ditre, & 
Brandon., 2010), which the Contemplation Ladder may not capture. Last but not least, it is worth 
noting that our lack of mediational evidence in this area could also be explained by the makeup 
of our sample and the treatment setting.  Our participants were veterans who actively sought out 
substance use treatment for one reason or another (self-imposed motivation to change behavior 
or court mandated treatment for substance use).  It may be that their motivation and self-efficacy 
to change problematic behaviors were already influenced by their enrollment in the substance 
use program.  
We also found that number of medical conditions and prescribed medications for these 
conditions predicted smoking cessation treatment-seeking behavior. It is possible that patients 
who have more diagnoses and are using more medications are the ones who are most 
comfortable seeking help in general, which could explain why they also seek smoking cessation 
help. Another explanation is that individuals with more medical conditions may be more likely to 
have access to and contact with health providers at the VA, which could increase opportunities 
for individuals to ask for smoking cessation aid.  
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Limitations 
Although the findings of the present study are encouraging, it has a number of limitations 
that are worth considering.  First, we only collected outcome data on the participants exiting a 
four-week outpatient treatment program for substance use and did not collect follow-up data on 
the participants’ smoking status.  The ultimate goal is to promote actual smoking cessation, so 
future studies should extend outcomes to include this behavior change in addition to initial 
treatment-seeking.  Albeit, MI alone may be insufficient for producing smoking cessation in 
many individuals, which is why treatment-seeking and engagement are worthy proximal 
outcomes.  Second, we did not record smoking cessation treatment compliance. Future studies 
may find this information valuable, as just requesting services does not necessarily mean that 
these services are going to be utilized effectively. Third, our randomization was not entirely 
effective as there were significant differences between groups on key baseline variables, 
particularly motivation to quit smoking.  Fourth, the study was conducted at an outpatient 
substance use clinic at a VA hospital.  The results from this study may not represent the general 
population or groups of smokers with different needs. Fifth, the weekly tobacco recovery 
education class posed a limitation for this study as it provided information to participants that 
could have motivated them to seek help quitting smoking. However, this class has not resulted in 
more than 10% spontaneous smoking cessation treatment-seeking behavior and it was provided 
to all participants in this study regardless of condition. Although not a limitation, we included an 
active control group, which might have reduced the likelihood of finding differences between 
groups, and it prevented us from quantifying the effect of MI compared to no treatment. Finally, 
as noted earlier, our study was powered only to examine the effectiveness of an MI intervention 
on engaging veteran smokers undergoing treatment for substance dependence in smoking 
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cessation treatment.  As an exploratory aim, we wanted to examine the intervention’s 
mechanisms of change.  However, our study was not powered for mediation analyses.  Future 
studies may consider replicating this study with a larger sample size, powered for more 
sophisticated process analyses. 
Conclusion and Implications 
 In conclusion, this study found that veteran smokers undergoing treatment for substance 
dependence may be receptive to messages about smoking cessation.  However, the way in which 
these messages are delivered appears to make a difference.  In the case of our study, an MI 
approach led to more veteran smokers seeking help to quit smoking (40%) than a health 
education modality.  It is important to note, however, that 23% of participants in the health 
education condition sought treatment to quit smoking, which is higher than would be expected 
for non-active control groups.  Previous studies that included usual care control groups found a 
rate of treatment-seeking behavior approximately 10% (Daley et al., 1998; Martino et al., 1999; 
Steinberg et al., 2004).   This suggests that educating veteran smokers about the health effects of 
cigarette smoking is somewhat helpful; however, using an MI approach with this population 
appears to be more effective in leading veteran smokers to take action to quit smoking.  The 
findings from the health education control condition could be more promising than problematic, 
as it may elucidate the fact that simply discussing smoking cessation with individuals and the 
consequences on their health may make them more likely to seek smoking cessation treatments. 
The latter may support the idea that something is better than nothing and in settings that lack MI 
training, health education may lead some smokers to seek services to quit smoking. 
Although it was not measured in our study, smokers (veterans or not) who are undergoing 
treatment for smoking cessation do not appear to be at risk for relapse to other abused substances 
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(e.g., Cooney et al., 2009).  In fact, ample evidence suggests that concurrent smoking cessation 
and substance dependence treatment are more likely to maintain patients’ recovery from 
substances.  This evidence points to the importance of engaging individuals in treatment for 
smoking cessation, as this is the first step towards quitting smoking. Furthermore, in medical 
settings, brief motivational interventions may be all that is feasible to deliver to patients. 
Although small, this study showed that a brief motivational intervention promoted access to 
smoking cessation resources, and such an intervention could be implemented in many types of 
treatment environments, including primary care and other specialty clinics. Given the relative 
success seen in our study, it would be interesting to see how effective brief MI interventions are 
in other medical settings and how they might dovetail with utilization of the 5A’s by healthcare 
providers.  Of course, this motivational intervention will need to be paired with evidence-based 
cessation interventions to capitalize upon the motivational enhancement.  Possibilities for such 
interventions include pharmacotherapy, brief physician advice (e.g., the “5 A’s”), telephone 
quitlines, self-help (e.g., Brandon, Simmons, Sutton, Unrod, Harrell et al., 2016), through 
intensive face-to-face counseling (see Fiore et al., 2008, for review of interventions and 
efficacies). In sum, this study provides encouragement that even for a population as challenging 
as veterans receiving substance abuse treatment, a brief motivational intervention can initiate the 
process of smoking cessation, with its numerous documented downstream health benefits. 
   
  
 
 
46 
 
 
 
 
References 
 
Acton, G. S., Prochaska, J. J., Kaplan, A. S., Small, T., & Hall, S. M. (2001). Depression and 
stages of change for smoking in psychiatric outpatients. Addictive Behaviors, 26(5), 621-
631. 
American Psychiatric Association (Ed.). (2006). American Psychiatric Association Practice 
Guidelines for the Treatment of Psychiatric Disorders: Compendium 2006. American 
Psychiatric Publication. 
Baker, A., Richmond, R., Haile, M., Lewin, T. J., Carr, V. J., Taylor, R. L., & Wilhelm, K. 
(2006). A randomized controlled trial of a smoking cessation intervention among people 
with a psychotic disorder. American Journal of Psychiatry,163(11), 1934-42. 
Bastian, L. A., & Sherman, S. E. (2010). Effects of the wars on smoking among 
veterans. Journal of General Internal Medicine, 25(2), 102-103. 
Biener, L., & Abrams, D. B. (1991). The Contemplation Ladder: Validation of a measure of 
readiness to consider smoking cessation. Health Psychology, 10(5), 360. 
Brandon, T. H., Simmons, V. N., Sutton, S. K., Unrod, M., Harrell, P. T., Meade, C. D., ... & 
Meltzer, L. R. (2016). Extended self-help for smoking cessation: a randomized controlled 
trial. American Journal of Preventive Medicine, 51(1), 54-62. 
Brown, D. W. (2010). Smoking prevalence among US veterans. Journal of General Internal 
Medicine, 25(2), 147-149. 
 
 
47 
 
Brown, S., Barraclough, B., & INSKIP, H. (2000). Causes of the excess mortality of 
schizophrenia. The British Journal of Psychiatry, 177(3), 212-217. 
Brown, R. A., Ramsey, S. E., Strong, D. R., Myers, M. G., Kahler, C. W., Lejuez, C. W., Niaura, 
R., Pallonen, U. E., Kazura, A. N., Goldstein, M. G., & Abrams, D. B. (2003). Effects of 
motivational interviewing on smoking cessation in adolescents with psychiatric 
disorders. Tobacco Control, 12(4), iv3-iv10. 
Burke, B. L., Arkowitz, H., & Menchola, M. (2003). The efficacy of motivational interviewing: 
A meta-analysis of controlled clinical trials. Journal of Consulting and Clinical 
Psychology, 71(5), 843. 
Cargill, B. R., Emmons, K. M., Kahler, C. W., & Brown, R. A. (2001). Relationship among 
alcohol use, depression, smoking behavior, and motivation to quit smoking with 
hospitalized smokers. Psychology of Addictive Behaviors,15(3), 272. 
CDC (2014) The health consequences of smoking—50 years of progress: a report of the surgeon 
general. Department of Health and Human Services, Centers for Disease Control and 
Prevention, Atlanta, GA. National Center for Chronic Disease Prevention and Health 
Promotion, Office on Smoking and Health, Washington, D.C. 2014 
http://www.surgeongeneral.gov/library/reports/50-years-ofprogress/. Accessed May 2014 
2. CDC (2008)  
Conway, T. L. (1998). Tobacco use and the United States military: A longstanding 
problem. Tobacco Control, 7(3), 219-221. 
Cooney, N. L., Cooney, J. L., Perry, B. L., Carbone, M., Cohen, E. H., Steinberg, H. R., Pilkey, 
D. T., Servarino, K., Oncken, C. A. & Litt, M. D. (2009). Smoking cessation during 
 
 
48 
 
alcohol treatment: A randomized trial of combination nicotine patch plus nicotine gum. 
Addiction, 104(9), 1588-1596. 
Copeland, L., McNamara, R., Kelson, M., & Simpson, S. (2015). Mechanisms of change within 
motivational interviewing in relation to health behaviors outcomes: A systematic 
review. Patient Education and Counseling, 98(4), 401-411 
Cronan, T. A. & Conway, T. L., (1989). Evaluations of smoking interventions in recruit training. 
Military Medicine, 154, 371-5. 
Daley, D. C., & Zuckoff, A. (1998). Improving compliance with the initial outpatient session 
among discharged inpatient dual diagnosis clients. Social Work, 43(5), 470-473. 
Department of Veterans Affairs. (2006). Integrating tobacco cessation treatment into mental 
health care. Washington, DC: Veterans Health Administration. 
Department of Veterans Affairs. (2011). Survey of veteran enrollees’ health and reliance upon 
VA. Available at: http//www. va. gov/healthpolicyplanning/soe2011/soe2011_report. pdf. 
Accessed March, 22, 2013. 
Deveci, S. E., Deveci, F., Açik, Y., & Ozan, A. T. (2004). The measurement of exhaled carbon 
monoxide in healthy smokers and non-smokers. Respiratory Medicine, 98(6), 551-556. 
Dierker, L. C., Avenevoli, S., Merikangas, K. R., Flaherty, B. P., & Stolar, M. (2001). 
Association between psychiatric disorders and the progression of tobacco use 
behaviors. Journal of the American Academy of Child & Adolescent Psychiatry, 40(10), 
1159-1167. 
Duffy, S. A., Biotti, J. K., Karvonen‐Gutierrez, C. A., & Essenmacher, C. A. (2011). Medical 
comorbidities increase motivation to quit smoking among veterans being treated by a 
psychiatric facility. Perspectives in Psychiatric Care, 47(2), 74-83. 
 
 
49 
 
Duffy, S. A., Essenmacher, C., Karvonen-Gutierrez, C., & A. Ewing, L. (2010). Motivation to 
quit smoking among veterans diagnosed with psychiatric and substance abuse 
disorders. Journal of Addictions Nursing, 21(2-3), 105-113. 
Duffy, S. A., Kilbourne, A. M., Austin, K. L., Dalack, G. W., Woltmann, E. M., Waxmonsky, J., 
& Noonan, D. (2012). Risk of smoking and receipt of cessation services among veterans 
with mental disorders. Psychiatric Services, 63(4), 325-332. 
Emmons, K. M., & Goldstein, M. G. (1992). Smokers who are hospitalized: A window of 
opportunity for cessation interventions. Preventive Medicine, 21(2), 262-269. 
Fiore, M. C., Jaen, C. R., Baker, T. B., Bailey, W. C., Bennett, G., Benowitz, N. L., & Dorfman, 
S. F. A. (2008). A clinical practice guideline for treating tobacco use and dependence: 
2008 update. A US Public Health Service report. American Journal of Preventive 
Medicine, 35(2), 158-76. 
Foley, K., Duran, B., Morris, P., Lucero, J., Jiang, Y., Baxter, B., Harrison, M., Shurley, M., 
Shorty, E., Darrell, J., Iralu, J., Davidson-Stroh, L., Foster, L., Begay, M., & Sonleiter, N. 
(2005). Using motivational interviewing to promote HIV testing at an American Indian 
substance abuse treatment facility. Journal of Psychoactive Drugs, 37(3), 321-329. 
Grant, B. F., Hasin, D. S., Chou, S. P., Stinson, F. S., & Dawson, D. A. (2004). Nicotine 
dependence and psychiatric disorders in the united states: Results from the national 
epidemiologic survey on alcohol and related conditions. Archives of General 
Psychiatry, 61(11), 1107-1115. 
Greenberg, G. A., & Rosenheck, R. A. (2004). Consumer satisfaction with inpatient mental 
health treatment in the Department of Veterans Affairs. Administration and Policy in 
Mental Health and Mental Health Services Research, 31(6), 465-481. 
 
 
50 
 
Hamlett-Berry, K., Davison, J., Kivlahan, D. R., Matthews, M. H., Hendrickson, J. E., & 
Almenoff, P. L. (2009). Evidence-based national initiatives to address tobacco use as a 
public health priority in the Veterans Health Administration. Military Medicine, 174(1), 
029-034. 
Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., & Fagerström, K. (1991). The Fagerström 
test for nicotine dependence: A revision of the Fagerström tolerance questionnaire. 
British Journal of Addiction, 86(9), 1119-1127.  
Helstrom, A., Hutchison, K., & Bryan, A. (2007). Motivational enhancement therapy for high-
risk adolescent smokers. Addictive Behaviors, 32(10), 2404-2410. 
Hettema, J. E., & Hendricks, P. S. (2010). Motivational interviewing for smoking cessation: A 
meta-analytic review. Journal of Consulting and Clinical Psychology, 78(6), 868. 
Hettema, J., Steele, J., & Miller, W. R. (2005). Motivational interviewing. Annual Review in 
Clinical Psychology. 1, 91-111. 
Hurt, R. D., Offord, K. P., Croghan, I. T., Gomez-Dahl, L., Kottke, T. E., Morse, R. M., & 
Melton, L. J. (1996). Mortality following inpatient addictions treatment: Role of tobacco 
use in a community-based cohort. Journal of the American Medical Association, 275(14), 
1097-1103. 
Institute of Medicine. (2009). Combating tobacco use in military and veteran populations. 
Jamal A, King B. A., Neff L. J., Whitmill J., Babb S. D., Graffunder C. M. (2016). Current 
cigarette smoking among adults — United States, 2005–2015. Morbidity and Mortality 
Weekly Report, 65, 1205–1211.  
Joseph, A. M. (1994). Is Congress blowing smoke at the VA? Journal of the American Medical 
Association, 272(15), 1215-1216. 
 
 
51 
 
Klevens, R. M., Giovino, G. A., Peddicord, J. P., Nelson, D. E., Mowery, P., & Grummer-
Strawn, L. (1994). The association between veteran status and cigarette-smoking 
behaviors. American Journal of Preventive Medicine, 11(4), 245-250. 
Knight, K. M., McGowan, L., Dickens, C., & Bundy, C. (2006). A systematic review of 
motivational interviewing in physical health care settings. British Journal of Health 
Psychology, 11(2), 319-332. 
Lai, D. T., Cahill, K., Qin, Y., & Tang, J. L. (2010). Motivational interviewing for smoking 
cessation. Cochrane Database Systematic Review, 1. 
Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. 
(2000). Smoking and mental illness: A population-based prevalence study. Journal of the 
American Medical Association, 284(20), 2606-2610. 
Lawn, S. J., Pols, R. G., & Barber, J. G. (2002). Smoking and quitting: A qualitative study with 
community-living psychiatric clients. Social Science & Medicine, 54(1), 93-104. 
Madson, M. B., Campbell, T. C., Barrett, D. E., Brondino, M. J., & Melchert, T. P. (2005). 
Development of the motivational interviewing supervision and training scale. Psychology 
of Addictive Behaviors, 19(3), 303-310. 
Madson, M. B., Loignon, A. C., & Lane, C. (2009). Training in motivational interviewing: A 
systematic review. Journal of Substance Abuse Treatment,36(1), 101-109. 
Martino, S., Carroll, K. M., O'Malley, S. S., & Rounsaville, B. J. (2000). Motivational 
interviewing with psychiatrically ill substance abusing patients. The American Journal on 
Addictions, 9(1), 88-91. 
 
 
52 
 
McCaffery, J. M., Niaura, R., Swan, G. E., & Carmelli, D. (2003). A study of depressive 
symptoms and smoking behavior in adult male twins from the NHLBI twin 
study. Nicotine & Tobacco Research, 5(1), 77-83. 
McKinney, W. P., McIntire, D. D., Carmody, T. J., & Joseph, A. (1997). Comparing the smoking 
behavior of veterans and nonveterans. Public Health Reports, 112(3), 212. 
Miller, C. E. (1999). Stages of change theory and the nicotine-dependent client: Direction for 
decision making in nursing practice. Clinical Nurse Specialist,13(1), 18-22. 
Miller, W. R. (1994). Motivational interviewing: III. On the ethics of motivational 
intervention. Behavioural and Cognitive Psychotherapy, 22(02), 111-123. 
Miller, W. R., & Rollnick, S. (1991). Motivational interviewing: Preparing people to change 
addictive behavior. Guilford. New York. 
Miller, W., & Rollnick, S. (2002). Motivational interviewing: Preparing people for change. 2nd 
The Guilford Press. New York. 
Morton, K., & Pradhan, S. C. (2001). Smoking cessation and major depression. Lancet, 
358(9286), 1011. 
Moyers, T. B., Martin, T., Manuel, J. K., Hendrickson, S. M., & Miller, W. R. (2005). Assessing 
competence in the use of motivational interviewing. Journal of Substance Abuse 
Treatment, 28(1), 19-26. 
Perkins, K. A., Karelitz, J. L., & Jao, N. C. (2013). Optimal carbon monoxide criteria to confirm 
24-hr smoking abstinence. Nicotine & Tobacco Research, 15(5), 978-982. 
Piñeiro, B., Míguez, M. D. C., & Becoña, E. (2010). La entrevista motivacional en el tratamiento 
del tabaquismo: una revisión. Adicciones: Revista de Socidrogalcohol, 22(4), 353-364. 
 
 
53 
 
Rollnick, S., Miller, W. R., & Butler, C. (2008). Motivational interviewing in health care: 
Helping patients change behavior. New York, NY: Guilford Press. 
Rubak, S., Sandbæk, A., Lauritzen, T., & Christensen, B. (2005). Motivational interviewing: A 
systematic review and meta-analysis. British Journal of General Practice, 55(513), 305-
312. 
Santa Ana, E. J., LaRowe, S. D., Armeson, K., Lamb, K. E., & Hartwell, K. (2016). Impact of 
group motivational interviewing on enhancing treatment engagement for homeless 
Veterans with nicotine dependence and other substance use disorders: A pilot 
investigation. The American Journal on Addictions, 25(7), 533-541. 
Shealy, S. E., & Winn, J. L. (2014). Integrating smoking cessation into substance use disorder 
treatment for military veterans: Measurement and treatment engagement 
efforts. Addictive Behaviors, 39(2), 439-444. 
Shealy, S. E., DeBaldo, J., Kropp, G., Gary, B., Egan-Blackwood, K., & Francis, E. (2001). 
ADATP Smoking Cessation Project. Unpublished Performance Improvement report. 
Simmons, V. N., Heckman, B. W., Ditre, J. W., & Brandon, T. H. (2010). A measure of smoking 
abstinence-related motivational engagement: development and initial validation. Nicotine 
& Tobacco Research, 12(4), 432-437. 
Steinberg, M. L., Ziedonis, D. M., Krejci, J. A., & Brandon, T. H. (2004). Motivational 
interviewing with personalized feedback: A brief intervention for motivating smokers 
with schizophrenia to seek treatment for tobacco dependence. Journal of Consulting and 
Clinical Psychology, 72(4), 723 
 
 
54 
 
Swanson, A. J., Pantalon, M. V., & Cohen, K. R. (1999). Motivational interviewing and 
treatment adherence among psychiatric and dually diagnosed patients. The Journal of 
Nervous and Mental Disease, 187(10), 630-635. 
US Department of Health and Human Services. (2014). The health consequences of smoking—
50 years of progress: a report of the Surgeon General. Atlanta, GA: US Department of 
Health and Human Services, Centers for Disease Control and Prevention, National 
Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and 
Health, 17.  
Volpp, K. G., Levy, A. G., Asch, D. A., Berlin, J. A., Murphy, J. J., Gomez, A., Sox, H., Zhu, & 
Lerman, C. (2006). A randomized controlled trial of financial incentives for smoking 
cessation. Cancer Epidemiology, Biomarkers and Prevention, 15(1), 12-18. 
Webb, M. S., de Ybarra, D. R., Baker, E. A., Reis, I. M., Carey, M. P. (2010). Cognitive-
behavioral therapy to promote smoking cessation among African-American smokers: A 
randomized clinical trial. Journal of Consulting and Clinical Psychology, 78, 24-33. 
Winn, J. L., Shealy, S. E., Markowitz, J. D., Joseph DeBaldo, M. B. A., Gonzales-Nolas, C., & 
Francis, E. (2011). Promoting tobacco cessation during substance abuse 
treatment. Federal Practitioner, 28(17-20) 23-24, 26. 
Ziedonis, D. M., & Williams, J. M. (2003). Management of smoking in people with psychiatric 
disorders. Current Opinion in Psychiatry, 16(3), 305-315. 
Ziedonis, D. M., Williams, J. M., Steinberg, M. L., Smelson, D., Krejci, J., Sussner, B. D. & 
Founds, J. (2004). Addressing tobacco dependence among veterans with a psychiatric 
disorder: a neglected epidemic of major clinical and public health concern. VA in the 
 
 
55 
 
vanguard: building on success in smoking cessation. Washington, DC: Department of 
Veterans Affairs, 141-70. 
  
 
 
56 
 
 
 
 
Appendix A: 
VA Approval Letter 
 
 
 
 
57 
 
Appendix A: VA Approval Letter 
 
 
 
  
 
 
 
58 
 
 
 
 
Appendix B: 
USF IRB Approval Letter 
 
 
 
59 
 
Appendix B: USF IRB Approval Letter 
 
